Dr. Mark R. Pomaranski, MD

  • Traverse City, MI
  • Mohs-micrographic surgery physician
NPI1962511097PAC ID0941239842
Medicare services, 2024
1,205
Medicare patients, 2024
386
Part D claims, 2024
103
MIPS score, 2024
93
Industry payments
$1,938
Practice address
550 Munson Ave, Traverse City, MI 49686
Practice phone
Call (231) 935-8717
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Northwestern Michigan Dermatology

Traverse City, Michigan

See all 3 affiliations

Find Dr. Pomaranski's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mark R. Pomaranski is a mohs-micrographic surgery physician in Traverse City, Michigan

Dr. Pomaranski practices at Northwestern Michigan Dermatology in Traverse City, Michigan.

Dr. Pomaranski's NPI, 1962511097, was assigned on August 30, 2006. Dr. Pomaranski graduated from University of Michigan Medical School in 1995. Dr. Pomaranski holds Michigan license 43010676697.

NPI and contact details
Medicare PAC ID
0941239842
NPI enumeration date
August 30, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(231) 935-8717
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
57
Medical school graduation
1995

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mark R. Pomaranski practices at Northwestern Michigan Dermatology in Traverse City, Michigan

Dr. Pomaranski's primary practice is Northwestern Michigan Dermatology, at 550 Munson Ave, Traverse City, MI 49686 in Grand Traverse County. The practice phone is (231) 935-8717.

  • Northwestern Michigan Dermatology
    550 Munson Ave, Traverse City, MI 49686 · Grand Traverse CountyPhone(231) 935-8717

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Mark R. Pomaranski is affiliated with 2 sites of care and 1 medical group

Dr. Pomaranski's primary practice is Northwestern Michigan Dermatology in Traverse City, Michigan. The medical group on file is Northwestern Michigan Dermatology. Dmand AI also links Dr. Pomaranski to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Pomaranski

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Mark R. Pomaranski's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pomaranski practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Northwestern Michigan DermatologyAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Pomaranski practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mark R. Pomaranski is one of 31 mohs-micrographic surgery physicians in Michigan

Mohs-micrographic surgery is Dr. Pomaranski's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Pomaranski is licensed in Michigan.

Specialties and state licenses

  • Mohs-micrographic surgery, MichiganPrimaryLicense 43010676697 · taxonomy 207ND0101X

Mohs-micrographic surgery physicians near Dr. Pomaranski

Counts of mohs-micrographic surgery physicians with a Dmand AI profile, by place and practice. Each opens the list.

31mohs-micrographic surgery physicians in Michigan
2mohs-micrographic surgery physicians in Traverse City

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mark R. Pomaranski billed Medicare for 1,205 services in 2024

CMS data shows 1,205 Medicare services from Dr. Pomaranski across 10 procedure codes in 2024, for 386 Medicare patients. Medicare paid $328,068 for them. Every service was in an office.

Medicare services, 20241,205
Medicare patients386
Paid by Medicare$328,068
Procedure codes10

Dr. Pomaranski's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Surgery
2023: 6702024: 78717%
Office and hospital visits
2023: 3852024: 4189%

Dr. Pomaranski compared with the Michigan median for mohs-micrographic surgery physicians, 2024

  • Dr. Pomaranski
  • Michigan median
Medicare services
1,205vs 1,219Close to median
Medicare patients
386vs 3636% above
Part D claims
88vs 17851% below

Medians across 31 mohs-micrographic surgery physicians in Michigan with Dmand AI profiles that report each measure.

Dr. Pomaranski's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Pomaranski

Need commercial claims for Dr. Pomaranski?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Pomaranski and other mohs-micrographic surgery physicians in Michigan.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mark R. Pomaranski treated 386 Medicare patients in 2024, average age 78

CMS counts 386 Medicare patients who saw Dr. Pomaranski in 2024. The largest group is 75 to 84, with 160 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pomaranski's median patient age at 76, with 46% women.

Medicare patients, 2024386
Average age78
Average risk score1.06
Also on Medicaid4%

Dr. Pomaranski's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Pomaranski's Medicare patients by sex, 2024

  • Women17245%
  • Men21455%

Chronic conditions among Dr. Pomaranski's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure71%
  3. Arthritis42%
  4. Chronic kidney disease26%
  5. Ischemic heart disease24%
  6. Atrial fibrillation23%
  7. Cancer22%
  8. Anxiety17%

Share of Medicare patients with each condition. A patient can have several.

Dr. Pomaranski's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 76

Patient panel by sex, all payers

  • Women46%
  • Men54%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mark R. Pomaranski wrote 103 Medicare Part D claims in 2024

In 2024, Dr. Pomaranski wrote 103 Medicare Part D claims for 91 patients. 100% of them were for generic drugs. CMS names the drug for 88 of them, across 1 drug with 11 or more claims each, at $357 in total drug cost. In 2023, CMS named 87 claims across 1 drug.

Part D claims, 2024103
Drugs named by CMS1
Total drug cost$357
Part D patients91

Dr. Pomaranski's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Pomaranski's Part D claims, 2024

  • Antibiotics92%95 of 103 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 872024: 881%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. Pomaranski

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mark R. Pomaranski scored 93 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Pomaranski for performance year 2024, reported as part of a group. Dr. Pomaranski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of melanoma (skin cancer) excision by Dr. Pomaranski, more than 71% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes

Dr. Pomaranski's MIPS scores, performance year 2024

  • 93of 100Final score
  • 97.3of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 78of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Where Dr. Pomaranski ranks in Medicare procedure volume

Removal of skin cancer
70th percentile658 procedures
Melanoma (skin cancer) excision
71st percentile16 procedures
Removal of skin lesions
60th percentile13 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find mohs-micrographic surgery physicians like Dr. Pomaranski by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mark R. Pomaranski received $1,938 in industry payments from 2016 to 2025

CMS Open Payments shows 99 general payments to Dr. Pomaranski from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $498.

General payments to Dr. Pomaranski by program year, 2016 to 2025

General payments to Dr. Pomaranski by kind, 2016 to 2025

$1.9Kin total
  • Food and beverage$1,92499%
  • Education$141%

Companies that paid Dr. Pomaranski the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Pomaranski

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mark R. Pomaranski graduated from University of Michigan Medical School

Dr. Pomaranski graduated from University of Michigan Medical School in 1995.

  1. Medical schoolUniversity of Michigan Medical School

Source: Dmand AI Professional Profile Data

Sources for Dr. Mark R. Pomaranski's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mark R. Pomaranski

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mark R. Pomaranski's NPI number?

Dr. Mark R. Pomaranski's NPI number is 1962511097. It was assigned on August 30, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mark R. Pomaranski?

Dr. Mark R. Pomaranski is a mohs-micrographic surgery physician in Traverse City, Michigan. The primary specialty in the NPI Registry is MOHS-Micrographic Surgery Physician (taxonomy code 207ND0101X).

Where does Dr. Mark R. Pomaranski practice?

Dr. Pomaranski practices at 550 Munson Ave, Traverse City, MI 49686. Dr. Pomaranski's primary practice is Northwestern Michigan Dermatology in Traverse City, Michigan. Dmand AI also links Dr. Pomaranski to 1 group practice or clinic.

What is Dr. Mark R. Pomaranski's office phone number?

The practice phone on file for Dr. Pomaranski is (231) 935-8717.

What is Dr. Mark R. Pomaranski's medical license number?

Dr. Pomaranski holds Michigan license 43010676697.

What medical group is Dr. Mark R. Pomaranski part of?

Dr. Pomaranski is linked to Northwestern Michigan Dermatology.

Does Dr. Mark R. Pomaranski accept Medicare?

Yes. CMS data shows Dr. Pomaranski billed Medicare for 1,205 services in 2024, and Dr. Pomaranski accepts Medicare assignment.

What is Dr. Mark R. Pomaranski's MIPS score?

Dr. Pomaranski's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.

How many Medicare patients does Dr. Mark R. Pomaranski see?

CMS counts 386 Medicare patients who saw Dr. Pomaranski in 2024, with an average age of 78.

What services does Dr. Mark R. Pomaranski bill to Medicare?

In 2024, Dr. Pomaranski's most billed Medicare services were surgery: skin and soft tissue (17311), surgery: skin and soft tissue (17312) and office visit, established patient (99212).

Show 4 more questionsShow fewer questions

Where did Dr. Mark R. Pomaranski go to medical school?

Dr. Pomaranski graduated from University of Michigan Medical School in 1995.

What drugs does Dr. Mark R. Pomaranski prescribe most?

In 2024 Medicare Part D data, Dr. Pomaranski's most prescribed drugs by claims were Cephalexin.

Has Dr. Mark R. Pomaranski received payments from drug or device companies?

CMS Open Payments shows $1,938 in general payments to Dr. Pomaranski from 19 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Mark R. Pomaranski been practicing?

Dr. Pomaranski graduated from medical school in 1995, 31 years ago.

Selling to mohs-micrographic surgery practices?

See mohs-micrographic surgery physicians in Michigan by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)